Validation of a LC method for the analysis of zafirlukast in a pharmaceutical formulation.
A reversed-phase high-performance liquid chromatographic (HPLC) method was developed and validated for estimation of zafirlukast in a pharmaceutical formulation. Assay samples were extracted utilizing acetonitrile. Drug and internal standard were chromatographed on reversed-phase C18 columns, using mixtures of acetonitrile/water and the eluents were monitored at different wavelengths. The method was validated statistically for its linearity, accuracy, robustness and precision. Experimental design was used during validation to evaluate method robustness and for the determination of intermediate precision. Factors examined for statistical approaches include laboratory, day, analyst, instrument, different percentage of organic modifier, temperature, wavelength and flow-rate. Due to its simplicity and accuracy, the method may be used for routine quality control analysis.
Ficarra
R
R
Facoltà di Farmacia, Università Magna Graecia, Catanzaro, Italy.
Ficarra
P
P
Tommasini
S
S
Melardi
S
S
Calabrò
M L
ML
Furlanetto
S
S
Semreen
M
M
D018927:Anti-Asthmatic Agents / Q000032:analysis*; D002851:Chromatography, High Pressure Liquid / Q000379:methods*; D007211:Indoles; D004364:Pharmaceutical Preparations / Q000737:chemistry*; D048448:Phenylcarbamates; D013449:Sulfonamides; D014105:Tosyl Compounds / Q000032:analysis*
D018927:Anti-Asthmatic Agents; D007211:Indoles; D004364:Pharmaceutical Preparations; D048448:Phenylcarbamates; D013449:Sulfonamides; D014105:Tosyl Compounds; C062735:zafirlukast